López-Abán, J.; Vicente, B.; Kabbas-Piñango, E.; Hernández-Goenaga, J.; Sánchez-Montejo, J.; Aguiriano, M.; del Olmo, E.; Vanegas, M.; Patarroyo, M.A.; Muro, A.
T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine. J. Clin. Med. 2021, 10, 445.
https://doi.org/10.3390/jcm10030445
AMA Style
López-Abán J, Vicente B, Kabbas-Piñango E, Hernández-Goenaga J, Sánchez-Montejo J, Aguiriano M, del Olmo E, Vanegas M, Patarroyo MA, Muro A.
T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine. Journal of Clinical Medicine. 2021; 10(3):445.
https://doi.org/10.3390/jcm10030445
Chicago/Turabian Style
LĂłpez-Abán, Julio, BelĂ©n Vicente, ElĂas Kabbas-Piñango, Juan Hernández-Goenaga, Javier Sánchez-Montejo, MarĂa Aguiriano, Esther del Olmo, Magnolia Vanegas, Manuel Alfonso Patarroyo, and Antonio Muro.
2021. "T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine" Journal of Clinical Medicine 10, no. 3: 445.
https://doi.org/10.3390/jcm10030445
APA Style
López-Abán, J., Vicente, B., Kabbas-Piñango, E., Hernández-Goenaga, J., Sánchez-Montejo, J., Aguiriano, M., del Olmo, E., Vanegas, M., Patarroyo, M. A., & Muro, A.
(2021). T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine. Journal of Clinical Medicine, 10(3), 445.
https://doi.org/10.3390/jcm10030445